Recombinant Human ST6GalNAc2 (C-6His)

Description

EnkiLife provides the Recombinant Human ST6GalNAc2 (C-6His) protein,aslo know as Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 2,GalNAc Alpha-2,6-Sialyltransferase II,ST6GalNAc II,ST6GalNAcII,SThM,Sialyltransferase 7B,SIAT7-B,ST6GALNAC2,SIAT7B,SIATL1,STHM, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human ST6 Sialyltransferase 2 is produced by our Mammalian expression system and the target gene encoding Ser29-Arg374 is expressed with a 6His tag at the C-terminus.Accession:Q9UJ37. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:38.84 KDa. Background:Alpha-N-Acetylgalactosaminide α-2,6-Sialyltransferase 2 (ST6GALNAC2) belongs to the glycosyltransferase 29 family that adds sialic acids to the non-reducing ends of glycoconjugates. At the cell surface, these modifications play roles in cell-cell and cell-substrate interactions, bacterial adhesion and protein targeting. ST6GALNAC2 is localized to the Golgi apparatus membrane. ST6GALNAC2 is highly expressed in lactating mammary glands and the adult testis; it is expressed at lower levels in the kidney. ST6GALNAC2 can catalyze 2,6-sialylation of the Tn antigen.